Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

May 31, 2022

50715_rns_2022-05-31_85f74168-84c9-4996-af47-40cd70cecace.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

31 May 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase /Sale Totalnumberof sharesinvolved Total amountpaid / received Highest (H)prices paid/ received Lowest (L)prices paid/ received
CICC CustomerTrading Limited 30 May2022 Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginatingclient-driven dealing Purchase 50,900 $1,970,046.0000 $38.6617 $38.6617

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Ordinaryshares Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later thanthe close of the morning tradingsession on the trading day followingthe orginatingclient-driven dealing Sale 50,900 $1,970,043.7800 $38.7042 $38.7042

End

Note:

CICC Customer Trading Limited is an exempt principal trader connected with the Offeror.

Dealings were made for its own account.

CICC Customer Trading Limited is ultimately owned by China International Capital Corporation Limited.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.